Bone marrow- and adipose tissue-derived mesenchymal stem cells from donors with coronary artery disease; growth, yield, gene expression and the effect of oxygen concentration

References

• WHO. Cardiovascular diseases: World Health Organisation; 2019 [cited 2019 Jun 28]. Available from: https://www.who.int/cardiovascular_diseases/en/
   Google Scholar
• Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9(1):12.
   PubMed Web of Science ®Google Scholar
• Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015). Stem Cell Res Ther. 2016;7(1):82.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu F, Ma J, et al. Effect of stem cell transplantation on patients with ischemic heart failure: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther. 2019;10(1):125.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58(11):1095–1104.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012;21(14):2724–2752.
   PubMed Web of Science ®Google Scholar
• Ivanovic Z. Hypoxia or in situ normoxia: the stem cell paradigm. J Cell Physiol. 2009;219(2):271–275.
   PubMed Web of Science ®Google Scholar
• Haque N, Rahman MT, Abu Kasim NH, et al. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal. 2013;2013:1–12.
   Web of Science ®Google Scholar
• Estrada JC, Albo C, Benguria A, et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ. 2012;19(5):743–755.
   PubMed Web of Science ®Google Scholar
• Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood. 1993;82(7):2031–2037.
   PubMed Web of Science ®Google Scholar
• Abdollahi H, Harris LJ, Zhang P, et al. The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res. 2011;165(1):112–117.
   PubMed Web of Science ®Google Scholar
• Gaebel R, Furlani D, Sorg H, et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One. 2011;6(2):e15652–e52.
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim H, Cho H, et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem. 2007;20(6):867–876.
   PubMed Web of Science ®Google Scholar
• Rasmussen JG, Frobert O, Holst-Hansen C, et al. Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model. Cell Transplant. 2014;23(2):195–206.
   PubMed Web of Science ®Google Scholar
• Efimenko A, Starostina E, Kalinina N, et al. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med. 2011;9(1):10.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Cook BD, Terushkin V, et al. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol. 2009;219(2):449–458.
   PubMed Web of Science ®Google Scholar
• Samsonraj RM, Raghunath M, Nurcombe V, et al. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173–2185.
   PubMed Web of Science ®Google Scholar
• Sassoli CO, Bani D, Formigli L. Cardiac progenitor cells as target of cell and growth factor-based therapies for myocardial regeneration. Stem Cell Res Ther. 2013;S9. https://www.longdom.org/open-access/cardiac-progenitor-cells-as-target-of-cell-and-growth-factor-based-therapies-for-myocardial-regeneration-2157-7633.S9-004.pdf.
   Google Scholar
• Lotfy A, Salama M, Zahran F, et al. Characterization of mesenchymal stem cells derived from rat bone marrow and adipose tissue: a comparative study. Int J Stem Cells. 2014;7(2):135–142.
   PubMedGoogle Scholar
• Li CY, Wu XY, Tong JB, et al. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther. 2015;6(1):55.
   PubMed Web of Science ®Google Scholar
• Chen HT, Lee MJ, Chen CH, et al. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med. 2012;16(3):582–593.
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells. Ann N Y Acad Sci. 2009;1176(1):101–117.
   PubMed Web of Science ®Google Scholar
• Fraser JK, Wulur I, Alfonso Z, et al. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24(4):150–154.
   PubMed Web of Science ®Google Scholar
• De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101–109.
   PubMed Web of Science ®Google Scholar
• Eto H, Suga H, Matsumoto D, et al. Characterization of structure and cellular components of aspirated and excised adipose tissue. Plast Reconstr Surg. 2009;124(4):1087–1097.
   PubMed Web of Science ®Google Scholar
• Hassan M, Latif N, Yacoub M. Adipose tissue: friend or foe? Nat Rev Cardiol. 2012;9(12):689–702.
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294–1301.
   PubMed Web of Science ®Google Scholar
• Naftali‐Shani N, Itzhaki‐Alfia A, Landa‐Rouben N, et al. The origin of human mesenchymal stromal cells dictates their reparative properties. J Am Heart Assoc. 2013;2:e000253.
   PubMed Web of Science ®Google Scholar
• Kastrup J, Mygind ND, Qayyum AA, et al. Mesenchymal stromal cell therapy in ischemic heart disease. Scand Cardiovasc J. 2016;50(5–6):293–299.
   PubMed Web of Science ®Google Scholar
• Kim DS, Ko YJ, Lee MW, et al. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Cell Stress Chaperones. 2016;21(6):1089–1099.
   PubMed Web of Science ®Google Scholar
• Atkinson K. The biology and therapeutic application of mesenchymal cells, 2 volume set. Hoboken, New Yersey: John Wiley & Sons; 2017.
   Google Scholar
• Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2(12):1117–1133.
   PubMedGoogle Scholar
• Tsai CC, Yew TL, Yang DC, et al. Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res. 2012;2(3):148–159.
   PubMedGoogle Scholar
• Rasmussen JG, Frobert O, Pilgaard L, et al. Prolonged hypoxic culture and trypsinization increase the pro-angiogenic potential of human adipose tissue-derived stem cells. Cytotherapy. 2011;13(3):318–328.
   PubMed Web of Science ®Google Scholar
• Bourin P, Gadelorge M, Peyrafitte JA, et al. Mesenchymal progenitor cells: tissue origin, isolation and culture. Transfus Med Hemother. 2008;35(3):160–167.
   PubMed Web of Science ®Google Scholar
• Antebi B, Rodriguez LA, Walker KP, et al. Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):265–265.
   PubMed Web of Science ®Google Scholar
• He J, Cai Y, Luo LM, et al. Hypoxic adipose mesenchymal stem cells derived conditioned medium protects myocardial infarct in rat. Eur Rev Med Pharmaco. 2015;19:4397–4406.
   PubMed Web of Science ®Google Scholar
• Pham VP, Ngoc BY, Ngoc KP. Hypoxia promotes adipose-derived stem cell proliferation via VEGF. BMRAT. 2016;3:476–482.
   Google Scholar
• Varghese J, Griffin M, Mosahebi A, et al. Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther. 2017;8(1):45.
   PubMed Web of Science ®Google Scholar
• Qayyum AA, Kaur KP, Mathiasen AB, et al. Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment. Scand J Clin Lab Invest. 2017;77(7):541–548.
   PubMed Web of Science ®Google Scholar